Chronic alcohol consumption accelerates liver injury in T cell-mediated hepatitis: Alcohol disregulation of NF-κB and STAT3 signaling pathways

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 287, Issue 2 50-2, 2004, Pages

  Jaruga, Barbara ^a   Hong, Feng ^a   Kim, Won Ho ^a   Sun, Rui ^a   Fan, Saijun ^b   Gao, Bin ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alcoholic liver injury; Concanavalin A; Nuclear factor B; STAT3

Indexed keywords

ALCOHOL; CONCANAVALIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT3 PROTEIN;

ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ALCOHOL DRINKING; ANIMALS; CELL ADHESION MOLECULES; CHEMOKINES; CONCANAVALIN A; DNA-BINDING PROTEINS; ETHANOL; HEPATITIS, TOXIC; HEPATOCYTES; KILLER CELLS, NATURAL; LEUKOCYTES; LIVER; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; NF-KAPPA B; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TIME FACTORS; TRANS-ACTIVATORS;

EID: 3242700529     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00018.2004     Document Type: Article

References (51)

1. Arteel GE. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 124: 778-790, 2003.
2. Bhattacharya R and Shuhart MC. Hepatitis C and alcohol: interactions, outcomes, and implications. J Clin Gastroenterol 36: 242-252, 2003.
3. Bogdanos DP, Mieli-Vergani G, and Vergani D. Virus, liver and autoimmunity. Dig Liver Dis 32: 440-446, 2000.
4. Bone-Larson CL, Simpson KJ, Colletti LM, Lukacs NW, Chen SC, Lira S, Kunkel SL, and Hogaboam CM. The role of chemokines in the immunopathology of the liver. Immunol Rev 177: 8-20, 2000.
5. Bosron WF, Lumeng L, and Li TK. Genetic polymorphism of enzymes of alcohol metabolism and susceptibility to alcoholic liver disease. Mol Aspects Med 10: 147-158, 1988.
6. Cao Q, Batey R, Pang G, and Clancy R. Altered T-lymphocyte responsiveness to polyclonal cell activators is responsible for liver cell necrosis in alcohol-fed rats. Alcohol Clin Exp Res 22: 723-729, 1998.
7. Cao Q, Batey R, Pang G, and Clancy R. Ethanol-altered liver-associated T cells mediate liver injury in rats administered Concanavalin A (Con A) or lipopolysaccharide (LPS). Alcohol Clin Exp Res 23: 1660-1667, 1999.
8. Chang KM, Thimme R, Melpolder JJ, Oldach D, Pemberton J, Moorhead-Loudis J, McHutchison JG, Alter HJ, and Chisari FV. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology 33: 267-276, 2001.
9. Chen J, Bao H, Sawyer S, Kunos G, and Gao B. Effects of short and long term ethanol on the activation of signal transducer and activator transcription factor 3 in normal and regenerating liver. Biochem Biophys Res Commun 239: 666-669, 1997.
10. Chen J, Kunos G, and Gao B. Ethanol rapidly inhibits IL-6-activated STAT3 and C/EBP mRNA expression in freshly isolated rat hepatocytes. FEBS Lett 457: 162-168, 1999.
11. Ciesielski CJ, Andreakos E, Foxwell BM, and Feldmann M. TNFα-induced macrophage chemokine secretion is more dependent on NF-κB expression than lipopolysaccharides-induced macrophage chemokine secretion. Eur J Immunol 32: 2037-2045, 2002.
12. Crabb DW. Ethanol oxidizing enzymes: roles in alcohol metabolism and alcoholic liver disease. Prog Liver Dis 13: 151-172, 1995.
13. Crabb DW, Dipple KM, and Thomasson HR. Alcohol sensitivity, alcohol metabolism, risk of alcoholism, and the role of alcohol and aldehyde dehydrogenase genotypes. J Lab Clin Med 122: 234-240, 1993.
14. Day CP. Who gets alcoholic liver disease: nature or nurture? J R Coll Physicians Lond 34: 557-562, 2000.
15. De la M Hall P, Lieber CS, DeCarli LM, French SW, Lindros KO, Jarvelainen H, Bode C, Parlesak A, and Bode JC. Models of alcoholic liver disease in rodents: a critical evaluation. Alcohol Clin Exp Res 25 Suppl 5: 254S-261S, 2001.
16. French SW and Tsukamoto H. Animal models for alcoholic liver disease. Hepatology 10: 898-899, 1989.
17. Grant BF, Dufour MC, and Harford TC. Epidemiology of alcoholic liver disease. Semin Liver Dis 8: 12-25, 1988.
18. Grove M and Plumb M. C/EBP, NF-κB, and c-Ets family members and transcriptional regulation of the cell-specific and inducible macrophage inflammatory protein 1α immediate-early gene. Mol Cell Biol 13: 5276-5289, 1993.
19. Heneghan MA and McFarlane IG. Current and novel immunosuppresive therapy for autoimmune hepatitis. Hepatology 35: 7-13, 2002.
20. Hill DB, Barve S, Joshi-Barve S, and McClain C. Increased monocyte nuclear factor-κB activation and tumor necrosis factor production in alcoholic hepatitis. J Lab Clin Med 135: 387-395, 2000.
21. Hong F, Jaruga B, Kim WH, Radaeva S, El-Assal ON, Tian Z, Nguyen VA, and Gao B. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest 110: 1503-1513, 2002.
22. Jaruga B, Hong F, Sun R, Radaeva S, and Gao B. Crucial Role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. J Immunol 171: 3233-3244, 2003.
23. Kishore R, Hill JR, McMullen MR, Frenkel J, and Nagy LE. ERK1/2 and Egr-1 contribute to increased TNF-α production in rat Kupffer cells after chronic ethanol feeding. Am J Physiol Gastrointest Liver Physiol 282: G6-G15, 2002.
24. Kishore R, McMullen MR, and Nagy LE. Stabilization of tumor necrosis factor α mRNA by chronic ethanol: role of A + U-rich elements and p38 mitogen-activated protein kinase signaling pathway. J Biol Chem 276: 41930-41937, 2001.
25. Kita H, Mackay IR, Van De Water J, and Gershwin ME. The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterology 120: 1485-1501, 2001.
26. Koteish A, Yang S, Lin H, Huang X, and Diehl AM. Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting Jun N-terminal kinase and caspase 3 activation. J Biol Chem 277: 13037-13044, 2002.
27. Lieber CS. Susceptibility to alcohol-related liver injury. Alcohol Alcohol Suppl 2: 315-326, 1994.
28. Lieber CS and DeCarli LM. Alcoholic liver injury: experimental models in rats and baboons. Adv Exp Med Biol 59: 379-393, 1975.
29. + LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis. Hepatology 24: 1416-1421, 1996.
30. Lumeng L and Crabb DW. Genetic aspects and risk factors in alcoholism and alcoholic liver disease. Gastroenterology 107: 572-578, 1994.
31. McClain CJ, Barve S, Deaciuc I, and Hill DB. Tumor necrosis factor and alcoholic liver disease. Alcohol Clin Exp Res 22: 248S-252S, 1998.
32. Nagy LE. Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp Biol Med (Maywood) 228: 882-890, 2003.
33. Nanji AA, Jokelainen K, Rahemtulla A, Miao L, Fogt F, Matsumoto H, Tahan SR, and Su GL. Activation of nuclear factor κB and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 30: 934-943, 1999.
34. Nguyen VA, Chen J, Hong F, Ishac EJ, and Gao B. Interferons activate the p42/44 mitogen-activated protein kinase and JAK-STAT (Janus kinase-signal transducer and activator transcription factor) signaling pathways in hepatocytes: differential regulation by acute ethanol via a protein kinase C-dependent mechanism. Biochem J 349: 427-434, 2000.
35. Peters MG and Terrault NA. Alcohol use and hepatitis C. Hepatology 36, Suppl 1: S220-S225, 2002.
36. Radaeva S, Jaruga B, Hong F, Kim WH, Fan S, Cai H, Strom S, Liu Y, El-Assal O, and Gao B. Interferon-α activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes. Gastroenterology 122: 1020-1034, 2002.
37. Roebuck KA and Finnegan A. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol 66: 876-888, 1999.
38. + T cells by flow cytometry: correlation with clinical disease stages. Hepatology 35: 190-198, 2002.
39. Schiff ER. Hepatitis C and alcohol. Hepatology 26, Suppl 1: 39S-42S, 1997.
40. Schneider T and Issekutz AC. Quantitation of eosinophil and neutrophil infiltration into rat lung by specific assays for eosinophil peroxidase and myeloperoxidase. Application in a Brown Norway rat model of allergic pulmonary inflammation. J Immunol Methods 198: 1-14, 1996.
41. Sermon F, Le Moine O, Gustot T, Quertinmont E, Louis H, Nagy N, Degraef C, and Deviere J. Chronic alcohol exposure sensitizes mice to galactosamine-induced liver injury through enhanced keratinocyte chemoattractant and defective IL-10 production. J Hepatol 39: 68 -76, 2003.
42. Shi L, Kishore R, McMullen MR, and Nagy LE. Chronic ethanol increases lipopolysaccharide-stimulated Egr-1 expression in RAW 264.7 macrophages: contribution to enhanced tumor necrosis factor α production. J Biol Chem 277: 14777-14785, 2002.
43. Simpson KJ, Henderson NC, Bone-Larson CL, Lukacs NW, Hogaboam CM, and Kunkel SL. Chemokines in the pathogenesis of liver disease: so many players with poorly defined roles. Clin Sci (Lond) 104: 47-63, 2003.
44. Szabo G. New insights into the the molecular mechanisms of alcoholic hepatitis: a potential role for NF-κB activation? J Lab Clin Med 135: 367-369, 2000.
45. Takeda K, Hayakawa Y, Van Kaer L, Matsuda H, Yagita H, and Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 97: 5498-5503, 2000.
46. Tiegs G. Experimental hepatitis and role of cytokines. Acta Gastroenterol Belg 60: 176-179, 1997.
47. Tiegs G, Hentschel J, and Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 90: 196-203, 1992.
48. Trautwein C, Rakemann T, Brenner DA, Streetz K, Licato L, Manns MP, and Tiegs G. Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice. Gastroenterology 114: 1035-1045, 1998.
49. Uesugi T, Froh M, Arteel GE, Bradford BU, Gabele E, Wheeler MD, and Thurman RG. Delivery of IκB superrepressor gene with adenovirus reduces early alcohol-induced liver injury in rats. Hepatology 34: 1149-1157, 2001.
50. Wolf D, Schumann J, Koerber K, Kiemer AK, Vollmar AM, Sass G, Papadopoulos T, Bang R, Klein SD, Brune B, and Tiegs G. Low-molecular-weight hyaluronic acid induces nuclear factor-κB-dependent resistance against tumor necrosis factor α-mediated liver injury in mice. Hepatology 34: 535-547, 2001.
51. Zhou Z, Wang L, Song Z, Lambert JC, McClain CJ, and Kang YJ. A critical involvement of oxidative stress in acute alcohol-induced hepatic TNF-α production. Am J Pathol 163: 1137-1146, 2003.